User contributions
From WikiPathways
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
- 14:21, 20 July 2016 Mus musculus:Dysregulated miRNA targeting in insulin/PI3K-AKT signaling (Modified description)
- 14:09, 20 July 2016 Mus musculus:Dysregulated miRNA targeting in insulin/PI3K-AKT signaling (Added Citation)
- 13:51, 20 July 2016 N Mus musculus:Dysregulated miRNA targeting in insulin/PI3K-AKT signaling (New pathway)
- 14:15, 19 July 2016 Homo sapiens:TLR4 signaling and tolerance (Added details from another source and cited)
- 14:08, 19 July 2016 Homo sapiens:TLR4 signaling and tolerance (Periodical save, work in progress)
- 13:50, 19 July 2016 Homo sapiens:ERK pathway in Huntington's disease (Modified description)
- 13:43, 19 July 2016 Homo sapiens:ERK pathway in Huntington's disease (Modified title)
- 13:43, 19 July 2016 N Homo sapiens:ERK pathway in Huntington's disease (New pathway)
- 19:57, 18 July 2016 N Homo sapiens:TLR4 signaling and tolerance (New pathway)
- 18:49, 18 July 2016 Homo sapiens:Physico-chemical features and toxicity-associated pathways (Fixed Unconnected Lines)
- 18:26, 18 July 2016 Homo sapiens:BDNF-TrkB signaling (Reverted to version '01:18, 18 July 2016' by <a href="/index.php/User:AAR%26Co" title="User:AAR&Co">AAR&Co</a>)
- 18:25, 18 July 2016 Homo sapiens:BDNF-TrkB signaling (Reverted to version '13:09, 1 July 2016' by <a href="/index.php/User:AAR%26Co" title="User:AAR&Co">AAR&Co</a>)
- 17:20, 18 July 2016 Homo sapiens:Canonical and non-canonical Notch signaling (Fixed Unconnected Lines)
- 17:17, 18 July 2016 Homo sapiens:PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer (Fixed Unconnected Lines)
- 17:15, 18 July 2016 Drosophila melanogaster:Toll, IMD, JAK/STAT pathways for immune response to pathogens (Fixed Unconnected Lines)
- 15:33, 18 July 2016 Homo sapiens:MAPK and NFkB signaling inhibited by Yersinia YopJ (Added Identifier)
- 15:27, 18 July 2016 N Homo sapiens:MAPK and NFkB signaling inhibited by Yersinia YopJ (New pathway)
- 13:09, 18 July 2016 Drosophila melanogaster:Toll, IMD, JAK/STAT pathways for immune response to pathogens (Modified description)
- 23:26, 11 July 2016 Homo sapiens:Canonical and non-canonical Notch signaling (Modified description)
- 23:25, 11 July 2016 N Homo sapiens:Canonical and non-canonical Notch signaling (New pathway)
- 23:23, 11 July 2016 Homo sapiens:PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer (Modified description)
- 23:22, 11 July 2016 N Homo sapiens:PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer (New pathway)
- 10:45, 11 July 2016 Drosophila melanogaster:Toll, IMD, JAK/STAT pathways for immune response to pathogens (Modified description)
- 10:22, 11 July 2016 Drosophila melanogaster:Toll, IMD, JAK/STAT pathways for immune response to pathogens (Modified description)
- 10:10, 11 July 2016 Drosophila melanogaster:Toll, IMD, JAK/STAT pathways for immune response to pathogens (Modified description)
- 09:24, 11 July 2016 N Drosophila melanogaster:Toll, IMD, JAK/STAT pathways for immune response to pathogens (New pathway)
- 12:59, 9 July 2016 Mus musculus: Hfe effect on hepcidin production (Modified description)
- 12:58, 9 July 2016 Mus musculus: Hfe effect on hepcidin production (Modified description)
- 12:56, 9 July 2016 Mus musculus: Hfe effect on hepcidin production (Update Source)
- 12:49, 9 July 2016 Homo sapiens:Amplification and expansion of oncogenic pathways as metastatic traits (Change of Title)
- 13:23, 1 July 2016 Homo sapiens:Physico-chemical features and toxicity-associated pathways (Modified description)
- 13:23, 1 July 2016 N Homo sapiens:Physico-chemical features and toxicity-associated pathways (New pathway)
- 13:19, 1 July 2016 Homo sapiens:Cell-type dependent selectivity of CCK2R signaling (Modified description)
- 13:18, 1 July 2016 N Homo sapiens:Cell-type dependent selectivity of CCK2R signaling (New pathway)
- 13:16, 1 July 2016 Homo sapiens:Amplification and expansion of oncogenic pathways as metastatic traits (Modified description)
- 13:15, 1 July 2016 N Homo sapiens:Amplification and expansion of oncogenic pathways as metastatic traits (New pathway)
- 13:09, 1 July 2016 Homo sapiens:BDNF-TrkB signaling (Modified description)
- 13:08, 1 July 2016 N Homo sapiens:BDNF-TrkB signaling (New pathway)
- 13:06, 1 July 2016 Mus musculus:Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling (Modified description)
- 13:06, 1 July 2016 N Mus musculus:Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling (New pathway)
- 12:59, 1 July 2016 Homo sapiens:Tgif disruption of Shh signaling (Modified description)
- 12:48, 1 July 2016 N Homo sapiens:Tgif disruption of Shh signaling (New pathway)
- 12:47, 1 July 2016 AAR&Co
- 12:44, 1 July 2016 Mus musculus: Hfe effect on hepcidin production (Modified description)
- 12:42, 1 July 2016 N Mus musculus: Hfe effect on hepcidin production (New pathway)
- 11:10, 25 June 2016 Homo sapiens:Interactions between LOXL4 and oxidative stress pathway (Modified description)
- 10:56, 25 June 2016 Homo sapiens:Interactions between LOXL4 and oxidative stress pathway (Add Citation)
- 10:54, 25 June 2016 N Homo sapiens:Interactions between LOXL4 and oxidative stress pathway (New pathway)
- 20:03, 21 June 2016 Homo sapiens:Hypothesized pathways in pathogenesis of cardiovascular disease (Modified description)
- 19:58, 21 June 2016 Homo sapiens:Hypothesized pathways in pathogenesis of cardiovascular disease (Modified description)
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
